Dipeptidyl peptidase inhibitor PT-100 suppresses tumor growth in vivo and enhances chemotherapy in mice.

被引：0
|
作者：
Adams, S [1 ]
Miller, GT [1 ]
Jones, B [1 ]
机构：
[1] Point Therapeut Inc, Boston, MA USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6229S / 6230S
页数：2
相关论文
共 50 条
  • [1] Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy
    Nemunaitis, John
    Vukelja, Svetislava J.
    Richards, Donald
    Cunningham, Casey
    Senzer, Neil
    Nugent, John
    Duncan, Houston
    Jones, Barry
    Haltom, Eric
    Uprichard, Margaret J.
    CANCER INVESTIGATION, 2006, 24 (06) : 553 - 561
  • [2] Parthenolide, An NF-κB Inhibitor, Suppresses Tumor Growth and Enhances Response to Chemotherapy in Gastric Cancer
    Sohma, Itsuro
    Fujiwara, Yoshiyuki
    Sugita, Yurika
    Yoshioka, Akiko
    Shirakawa, Mitsuhiro
    Moon, Jeong-Ho
    Takiguchi, Shuj
    Miyata, Hiroshi
    Yamasaki, Makoto
    Mori, Masaki
    Doki, Yuichiro
    CANCER GENOMICS & PROTEOMICS, 2011, 8 (01) : 39 - 47
  • [3] T-cell independent activity of talabostat (PT-100) against human tumor xenografts in mice
    Adams, S
    Miller, G
    Jones, B
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S54 - S54
  • [4] The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice
    Yorifuji, Naoki
    Inoue, Takuya
    Iguchi, Munetaka
    Fujiwara, Kaori
    Kakimoto, Kazuki
    Nouda, Sadaharu
    Okada, Toshihiko
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Higuchi, Kazuhide
    ONCOLOGY REPORTS, 2016, 35 (02) : 676 - 682
  • [5] The Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Suppresses Mouse Colon Tumorigenesis in Type 2 Diabetes Mice
    Yorifuji, Naoki
    Inoue, Takuya
    Fujiwara, Kaori
    Iguchi, Munetaka
    Kojima, Yuichi
    Okada, Toshihiko
    Kakimoto, Kazuki
    Nouda, Sadaharu
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Higuchi, Kazuhide
    GASTROENTEROLOGY, 2015, 148 (04) : S577 - S577
  • [6] PT-100, a small molecule dipeptidyl peptidase inhibitorg has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism
    Adams, S
    Miller, GT
    Jesson, MI
    Watanabe, T
    Jones, B
    Wallner, BP
    CANCER RESEARCH, 2004, 64 (15) : 5471 - 5480
  • [7] Molecular Inhibitor of QSOX1 Suppresses Tumor Growth In Vivo
    Fifield, Amber L.
    Hanavan, Paul D.
    Faigel, Douglas O.
    Sergienko, Eduard
    Bobkov, Andrey
    Meurice, Nathalie
    Petit, Joachim L.
    Polito, Alysia
    Caulfield, Thomas R.
    Castle, Erik P.
    Copland, John A.
    Mukhopadhyay, Debabrata
    Pal, Krishnendu
    Dutta, Shamit K.
    Luo, Huijun
    Ho, Thai H.
    Lake, Douglas F.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 112 - 122
  • [8] Synergistic renoprotective effects of green tea extract and dipeptidyl peptidase 4 inhibitor gemigliptin against tacrolimus-induced nephropathy in Mice.
    Shin, Byung-Chul
    Min Yoon, Young
    Min Lee, So
    Hoon Chung, Jong
    Lee Kim, Hyung
    TRANSPLANTATION, 2024, 108 (9S)
  • [9] A tyrosine kinase inhibitor and interleukin-12 synergize to inhibit tumor growth in mice.
    Burdelya, L
    Catlett-Falcone, R
    Levitzki, A
    Jove, R
    Yu, H
    CLINICAL CANCER RESEARCH, 1999, 5 : 3752S - 3752S
  • [10] A Dipeptidyl Peptidase-4 Inhibitor Suppresses Macrophage Foam Cell Formation in Diabetic db/db Mice and Type 2 Diabetes Patients
    Terasaki, Michishige
    Hiromura, Munenori
    Mori, Yusaku
    Kohashi, Kyoko
    Kushima, Hideki
    Koshibu, Masakazu
    Saito, Tomomi
    Yashima, Hironori
    Watanabe, Takuya
    Hirano, Tsutomu
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
12345